View More Recent Stories
-
Medicus Pharma (MDCX) Announces Collaboration Agreement to Expand Phase 2 Clinical Study in Asia Pacific Region
-
Medicus Pharma (MDCX) Appoints Faisal Mehmud as Chief Medical Officer
-
Medicus Pharma Ltd. Announces Closing of US$4.0M Initial Public Offering in the United States
-
Medicus Pharma Ltd. Announces Pricing of US$4.0M Initial Public Offering in the United States

